8-K

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                         PURSUANT TO SECTION 13 OR 15(D)
                     OF THE SECURITIES EXCHANGE ACT OF 1934



Date of report: July 12, 2002
(Date of earliest event reported:)




                               Moore Medical Corp.
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)



          Delaware                      1-8903                  22-1897821
- --------------------------------------------------------------------------------
(State or other jurisdiction       (Commission File          (I.R.S. Employer
     of incorporation)                 Number)             Identification No.)



  389 John Downey Drive P.O. Box 1500, New Britain, CT            06050
- --------------------------------------------------------------------------------
        (Address of principal executive offices)                (Zip Code)



                                 (860) 826-3600
- --------------------------------------------------------------------------------
               Registrant's telephone number, including area code




- --------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)



ITEM 5.     OTHER EVENTS
            ------------

            A copy of Moore Medical Corp.'s press release, dated July 12, 2002,
is attached hereto and also incorporated herein by reference.

ITEM 7.     FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
            ------------------------------------------------------------------

            (c) Exhibits:   The following documents are filed as exhibits to
                            this report:

            99.1            Press Release of Moore Medical Corp., dated
                            July 12, 2002.




                                    SIGNATURE

            Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                         Moore Medical Corp.


Date:  July 12, 2002                    /s/  Linda M. Autore
                                        ---------------------------------------
                                        Linda M. Autore
                                        President and Chief Executive Officer




                                  EXHIBIT INDEX

      99.1        Press Release of Moore Medical, dated July 12, 2002.

EX-99.1

                                                                    EXHIBIT 99.1




                  MOORE MEDICAL CORP. NAMES JOHN M. ZINZARELLA
                         INTERIM CHIEF FINANCIAL OFFICER

        ---------------------------------------------------------------

NEW BRITAIN, CT, July 12, 2002 - Moore Medical Corp. (AMEX:MMD), a leading
multi-channel specialty marketer and distributor of medical, surgical and
pharmaceutical products to health care professionals in non-hospital settings,
announced today that it has named John M. Zinzarella Interim Chief Financial
Officer.

      A health care industry executive with a broad range of experience serving
large organizations, Zinzarella joined Moore Medical in October 2001 as Vice
President, Controller and Chief Accounting Officer. Zinzarella has over 10 years
of financial management experience with Aventis Pasteur (formerly Pasteur
Merieux Connaught), and Wyeth Ayerst Laboratories. In his tenure with both
organizations, he partnered with executive management to streamline the
financial reporting structures, identified optimal strategies for commercial and
manufacturing capabilities and strengthened internal control systems. He began
his career with Ernst & Young and was a member of its audit group.

      Zinzarella holds an MBA from Villanova University, a BS in accounting from
Virginia Polytechnic Institute & State University, and is a certified public
accountant.

      The position of Chief Financial Officer was previously held by James R.
Simpson, who is leaving the Company to pursue other interests.


ABOUT MOORE MEDICAL
- -------------------

Moore Medical is an Internet-enabled multi-channel marketer and distributor of
medical, surgical and pharmaceutical products to over 100,000 health care
practices and facilities in non-hospital settings nationwide, including:
physicians; emergency medical technicians; schools; correctional institutions;
municipalities; occupational/industrial health doctors and nurses; and other
specialty practice communities. Moore Medical also serves the medical/surgical
supply needs of over 26 customer community affiliates. The Company markets and
serves its customers through direct mail, industry-specialized telephone support
staff, field sales representatives, and the Internet. Its direct marketing and
distribution business has been in operation for over 50 years. More information
about the Company, which recently enhanced the functionality of its web site,
can be found at www.mooremedical.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF
1995. This press release contains statements about future events and
expectations that constitute forward-looking statements under the federal
securities laws. These statements are characterized by words such as "believe,"
"may," "will," "could," "should," "would," "anticipate," "estimate," "expect,"
"intent," "project," "objective," "seek," "strive," "might," "seeks," "likely
result," "build," "grow," "plan," "goal," "expand," "position," or similar
words. Forward-looking statements involve risks and uncertainties (including
factors outside our control) that may cause our actual results, performance or
financial condition to differ materially from any future results implied by such
forward-looking statements. Factors that could contribute to these differences
include, but are not limited to: the inability to generate adequate revenues and
income from our strategy to transform the Company to a multi-channel e-commerce
enabled business; changes in demand for or supply of our products; online
security breaches; disruptions in or cost increases for third-party services or
systems; intense competition in health care product distribution; government
regulation of drug and medical device distribution, the Internet and health care
products and services; and changes in insurance coverage of health care products
and services. Further information regarding factors that could affect our
results and the statements made herein are included in our filings with the
Securities and Exchange Commission.